Department of Neurology, Saitama Medical University, Saitama, Japan.
Mov Disord. 2013 Mar;28(3):384-7. doi: 10.1002/mds.25243. Epub 2012 Nov 2.
PARK4 is a candidate locus for familial Parkinson's disease (PD), combined with multiplication of the α-synuclein gene (SNCA). The eventual phenotype is dependent on the copy number of SNCA. Mutations in leucine-rich repeat kinase 2 (LRRK2) are also causative of parkinsonism. This report describes a man who presented at our hospital complaining of a stagger after running and difficulty in handling the mouse of a personal computer, having suffered tremors since his twenties. Nine months after treatment and discharge, he developed titubation and began to drag his right foot.
We examined the patient's family pedigree for SNCA dosage, using quantitative polymerase chain reaction. We also screened this pedigree for mutations in parkin and LRRK2, using gene-sequencing techniques.
We identified the proband, his sister, and his paternal uncle as carrying a duplication of SNCA. In addition, we found that the proband and his mother carried the G2385R variant of the LRRK2, a strong risk factor for PD in Asians and the rare V1450I variant, although only the proband showed symptoms of parkinsonism. No mutations were found in parkin.
The combination of SNCA gene duplication and LRRK2 G2385R variant may explain the early onset of disease in this patient.
PARK4 是家族性帕金森病(PD)的候选基因座,与α-突触核蛋白基因(SNCA)的倍增有关。最终表型取决于 SNCA 的拷贝数。富亮氨酸重复激酶 2(LRRK2)的突变也是帕金森病的原因。本报告描述了一名男性患者,他因跑步后蹒跚和难以操作个人计算机鼠标而到我院就诊,自二十多岁起就患有震颤。治疗和出院九个月后,他出现了摇摆不稳,开始拖着右脚。
我们使用定量聚合酶链反应检查了患者的家族 SNCA 剂量,并使用基因测序技术筛查了该家族的 parkin 和 LRRK2 突变。
我们发现先证者、他的妹妹和他的叔公携带 SNCA 基因重复。此外,我们发现先证者和他的母亲携带 LRRK2 的 G2385R 变体,这是亚洲人 PD 的强危险因素,以及罕见的 V1450I 变体,尽管只有先证者表现出帕金森病的症状。未发现 parkin 基因突变。
SNCA 基因重复和 LRRK2 G2385R 变体的组合可能解释了该患者疾病的早发。